Avalo Therapeutics CMO Disposes $411K in Shares After Executing Options
Avalo Therapeutics Inc. (NASDAQ: AVTX) Chief Medical Officer Mittie Doyle sold 25,492 common shares on March 16, 2026, for $411,606 following the exercise of options to acquire an identical number of shares. The transactions coincide with recent analyst interest and a marked year-over-year share gain, while InvestingPro data flags the stock as trad…